CDKN2B Protein (Transcript Variant 2) (Myc-DYKDDDDK Tag)

N° du produit ABIN2713879

Détail du produit

Antigène: CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))

Type de proteíne: Recombinant

Attributs du protein: Transcript Variant 2

Origine: Humain

Source: HEK-293 Cells

Purification/Conjugué: Cette CDKN2B protéine est marqué à la Myc-DYKDDDDK Tag.

Application: Antibody Production (AbP), Standard (STD)

Attributs du produit:

• Recombinant human CDKN2B / p15INK4b (transcript variant 2) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Pureté: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Information d'application

Indications d'application: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Commentaires:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Stockage

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Stock: -80 °C

Stockage commentaire: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Détail du antigène

Antigène: CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))

Autre désignation: Cdkn2b,p15ink4b (CDKN2B Produits)

Synonymes: p14-INK4b Protein, cdk4l Protein, ink4b Protein, mts2 Protein, p15 Protein, p15ink4b Protein, tp15 Protein, CDK4I Protein, INK4B Protein, MTS2 Protein, P15 Protein, TP15 Protein, p15INK4b Protein, AV083695 Protein, INK4b Protein, p15(INK4b) Protein, CDKN2A Protein, cyclin dependent kinase inhibitor 2B Protein, Cyclin-dependent kinase 4 inhibitor B Protein, cyclin-dependent kinase inhibitor 2B Protein, cyclin-dependent kinase inhibitor 2B L homeolog Protein, cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) Protein, CDKN2B Protein, cdn2b Protein, cdkn2b Protein, cdkn2b.L Protein, Cdkn2b Protein

Sujet: Interacts strongly with CDK4 and CDK6. Potent inhibitor. Potential effector of TGF-beta induced cell cycle arrest. [UniProtKB/Swiss-Prot Function]

Poids moléculaire: 7.9 kDa

NCBI Accession: NP_511042

Pathways: Cycle Cellulaire, Mitotic G1-G1/S Phases